Search Results - "Helou, J"

Refine Results
  1. 1

    Palbociclib in hormone receptor positive advanced breast cancer: A cost-utility analysis by Raphael, J., Helou, J., Pritchard, K.I., Naimark, D.M.

    Published in European journal of cancer (1990) (01-11-2017)
    “…The addition of palbociclib to letrozole improves progression-free survival in the first-line treatment of hormone receptor positive advanced breast cancer…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Interictal sleep recordings during presurgical evaluation: Bidirectional perspectives on sleep related network functioning by Dinkelacker, V., El Helou, J., Frauscher, B.

    Published in Revue neurologique (01-09-2022)
    “…Sleep recordings are an integral part of presurgical evaluation in drug-resistant focal epilepsy. Physiological network functioning is substantially different…”
    Get full text
    Journal Article
  4. 4

    Long-Term Biochemical Control of a Prospective Cohort of Prostate Cancer Patients Treated With Interstitial Brachytherapy Versus Radical Prostatectomy by Sanmamed, N., Locke, G., Crook, J., Liu, A., Raman, S., Glicksman, R., Chung, P., Berlin, A., Fleshner, N., Helou, J.

    “…To report long-term oncological outcomes of men treated prospectively as part of the American College of Surgeons Oncology Group phase III Surgical…”
    Get full text
    Journal Article
  5. 5

    The genome-wide landscape of DNA methylation and hydroxymethylation in response to sleep deprivation impacts on synaptic plasticity genes by Massart, R, Freyburger, M, Suderman, M, Paquet, J, El Helou, J, Belanger-Nelson, E, Rachalski, A, Koumar, O C, Carrier, J, Szyf, M, Mongrain, V

    Published in Translational psychiatry (21-01-2014)
    “…Sleep is critical for normal brain function and mental health. However, the molecular mechanisms mediating the impact of sleep loss on both cognition and the…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Predictive factors for persistent and late radiation complications in breast cancer survivors by Fekrmandi, F., Panzarella, T., Dinniwell, R. E., Helou, J., Levin, W.

    Published in Clinical & translational oncology (01-03-2020)
    “…Purpose With improved diagnostic techniques and treatments of breast cancer, overall survival times are longer, giving more opportunity for normal tissue…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Evaluation of Nd:YAG laser device efficacy on onychomycosis: a case series of 30 patients by Helou, J., Maatouk, I., Hajjar, M. A., Moutran, R.

    Published in Mycoses (01-01-2016)
    “…Summary Until recently, pharmacologic molecules have been the only available treatments for onychomycosis. Laser treatments were introduced for recurrent or…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Restless legs syndrome among multiple sclerosis patients in Lebanon by Makhoul, J., Ghaoui, N., Sleilaty, G., Koussa, S., Abbas, S., Azar, C., El Helou, J.

    Published in Multiple sclerosis and related disorders (01-06-2020)
    “…•Multiple sclerosis patients frequently reported symptoms of restless legs syndrome.•Those affected were often found to have spinal demyelinating lesions on…”
    Get full text
    Journal Article
  14. 14

    Stereotactic Body Radiotherapy versus Low Dose Rate Brachytherapy for Localised Prostate Cancer: a Cost–Utility Analysis by Helou, J., Torres, S., Musunuru, H.B., Raphael, J., Cheung, P., Vesprini, D., Chung, H.T., D'Alimonte, L., Krahn, M., Morton, G., Loblaw, A.

    “…To conduct a cost–utility analysis comparing stereotactic body radiotherapy (SBRT) with low dose rate brachytherapy (LDR-BT) for localised prostate cancer…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20